Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-21T21:17:09.369Z Has data issue: false hasContentIssue false
  • English
  • Français

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

Published online by Cambridge University Press:  05 February 2002

H.-U. WITTCHEN ,
E. BECKER ,
R. LIEB  and
P. KRAUSE
H.-U. WITTCHEN
Affiliation:
From the Technical University of Dresden, Institute of Clinical Psychology and Psychotherapy, Dresden; and Max-Planck Institute of Psychiatry, Munich, Germany
E. BECKER
Affiliation:
From the Technical University of Dresden, Institute of Clinical Psychology and Psychotherapy, Dresden; and Max-Planck Institute of Psychiatry, Munich, Germany
R. LIEB
Affiliation:
From the Technical University of Dresden, Institute of Clinical Psychology and Psychotherapy, Dresden; and Max-Planck Institute of Psychiatry, Munich, Germany
P. KRAUSE
Affiliation:
From the Technical University of Dresden, Institute of Clinical Psychology and Psychotherapy, Dresden; and Max-Planck Institute of Psychiatry, Munich, Germany
Get access Rights & Permissions [Opens in a new window]

Abstract

Background. Despite an abundance of clinical research on premenstrual and menstrual symptoms, few epidemiological data provide estimates of the prevalence, incidence, co-morbidity, stability and correlates of premenstrual dysphoric disorder (PMDD) in the community.

Aims. To describe the prevalence, incidence, 12 co-morbidity factors and correlates of threshold and subthreshold PMDD in a community sample of young women.

Methods. Findings are based on prospective–longitudinal community survey of 1488 women aged 14–24, who were followed-up over a period of 48 months (follow-up, N = 1251) as part of the EDSP sample. Diagnostic assessments were based on the Composite International Diagnostic Interview (CIDI) and its 12-month PMDD diagnostic module administered by clinical interviewers. Diagnoses were calculated using DSM-IV algorithms, but daily ratings of symptoms, as required, were not available.

Results. The baseline 12-month prevalence of DSM-IV PMDD was 5·8%. Application of the diagnostic exclusion rules with regard to concurrent major depression and dysthymia decreased the rate only slightly (5·3%). An additional 18·6% were ‘near-threshold’ cases, mostly because they failed to meet the mandatory impairment criterion. Over the follow-up period only few new PMDD cases were observed: cumulative lifetime incidence was 7·4%. PMDD syndrome was stable across 48 months with <10% complete remissions among baseline PMDD cases. The 12-month and lifetime co-morbidity rates were high (anxiety disorders 47·4%, mood disorders 22·9%; somatoform 28·4%), only 26·5% had no other mental disorder. Particularly high odds ratios were found with nicotine dependence and PTSD. In terms of correlates increased rates of 4-weeks impairment days, high use of general health and mental health services, and increased rates of suicide attempts were found.

Conclusion. In this sample of adolescents and young adults, premenstrual symptoms were widespread. However, DSM-IV PMDD was considerably less prevalent. PMDD is a relatively stable and impairing condition, with high rates of health service utilization, increased suicidality and substantial co-morbidity.

Type
Original Article
Information
Psychological Medicine , Volume 32 , Issue 1 , January 2002 , pp. 119 - 132
Copyright
© 2002 Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)